
Bruce Jackson
Stock Analyst at StoneX
(0.08)
# 4,844
Out of 5,136 analysts
299
Total ratings
35.4%
Success rate
-11%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NEO NeoGenomics | Reiterated: Buy | $16 → $20 | $16.02 | +24.84% | 25 | Oct 6, 2026 | |
| UNCY Unicycive Therapeutics | Reiterated: Buy | $13 → $15 | $3.55 | +322.54% | 12 | Aug 20, 2026 | |
| PODD Insulet | Reiterated: Buy | $250 → $185 | $152.48 | +21.33% | 2 | Aug 6, 2026 | |
| DXCM DexCom | Reiterated: Buy | $77 → $82 | $83.33 | -1.60% | 2 | Jul 31, 2026 | |
| MMED MiniMed Group | Reiterated: Buy | $20 | $17.99 | +11.17% | 2 | Jun 3, 2026 | |
| HUMA Humacyte | Reiterated: Buy | $1 → $2 | $0.5584 | +258.17% | 23 | Jun 1, 2026 | |
| BFRI Biofrontera | Reiterated: Buy | $3 | $0.7001 | +328.51% | 20 | May 19, 2026 | |
| TNDM Tandem Diabetes Care | Initiated Coverage: Hold | n/a | $20.07 | - | 1 | May 11, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | $145 → $120 | $108.52 | +10.58% | 4 | Apr 17, 2026 | |
| CV CapsoVision | Reiterated: Buy | $14 → $10 | $6.03 | +65.84% | 5 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 → $20 | $1.87 | +972.39% | 11 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $6 | $9.39 | -36.10% | 18 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $187 → $217 | $164.36 | +32.03% | 21 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 | $3.92 | +690.82% | 18 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.25 → $1 | $0.307 | +225.73% | 6 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $16.31 | n/a | 20 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $280 → $140 | $0.35326 | n/a | 4 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.23 | n/a | 14 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $4.47 | n/a | 2 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.97 | n/a | 6 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $3 | $0.3209 | n/a | 6 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.35 → $2 | $1.89 | n/a | 6 | Jun 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $24 | $1.41 | n/a | 4 | Apr 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $1 | $0.3614 | n/a | 1 | Apr 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $960 → $240 | $0.000001 | n/a | 8 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $26.39 | n/a | 15 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $5 | $2.14 | n/a | 13 | Aug 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $0.8293 | n/a | 1 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $4 | $2.13 | n/a | 2 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.375 | n/a | 3 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $2.89 | n/a | 3 | Jun 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $1.09 | n/a | 1 | Jul 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $0.3105 | n/a | 3 | Apr 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $38 | $55.93 | n/a | 5 | Mar 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.21 | n/a | 5 | Feb 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $0.9146 | n/a | 1 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40 → $92 | $14.40 | n/a | 2 | Oct 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $46 | $102.86 | n/a | 2 | Nov 21, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $44.34 | n/a | 2 | Mar 2, 2012 |
NeoGenomics
Oct 6, 2026
Reiterated: Buy
Price Target: $16 → $20
Current: $16.02
Upside: +24.84%
Unicycive Therapeutics
Aug 20, 2026
Reiterated: Buy
Price Target: $13 → $15
Current: $3.55
Upside: +322.54%
Insulet
Aug 6, 2026
Reiterated: Buy
Price Target: $250 → $185
Current: $152.48
Upside: +21.33%
DexCom
Jul 31, 2026
Reiterated: Buy
Price Target: $77 → $82
Current: $83.33
Upside: -1.60%
MiniMed Group
Jun 3, 2026
Reiterated: Buy
Price Target: $20
Current: $17.99
Upside: +11.17%
Humacyte
Jun 1, 2026
Reiterated: Buy
Price Target: $1 → $2
Current: $0.5584
Upside: +258.17%
Biofrontera
May 19, 2026
Reiterated: Buy
Price Target: $3
Current: $0.7001
Upside: +328.51%
Tandem Diabetes Care
May 11, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $20.07
Upside: -
Abbott Laboratories
Apr 17, 2026
Reiterated: Buy
Price Target: $145 → $120
Current: $108.52
Upside: +10.58%
CapsoVision
Mar 27, 2026
Reiterated: Buy
Price Target: $14 → $10
Current: $6.03
Upside: +65.84%
Mar 20, 2026
Reiterated: Buy
Price Target: $23 → $20
Current: $1.87
Upside: +972.39%
Mar 16, 2026
Reiterated: Buy
Price Target: $20 → $6
Current: $9.39
Upside: -36.10%
Mar 3, 2026
Reiterated: Buy
Price Target: $187 → $217
Current: $164.36
Upside: +32.03%
Dec 3, 2025
Reiterated: Buy
Price Target: $31
Current: $3.92
Upside: +690.82%
Nov 20, 2025
Reiterated: Buy
Price Target: $1.25 → $1
Current: $0.307
Upside: +225.73%
Nov 7, 2025
Reiterated: Hold
Price Target: n/a
Current: $16.31
Upside: n/a
Sep 15, 2025
Reiterated: Buy
Price Target: $280 → $140
Current: $0.35326
Upside: n/a
Sep 15, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.23
Upside: n/a
Apr 24, 2025
Reiterated: Buy
Price Target: $30
Current: $4.47
Upside: n/a
Nov 26, 2024
Reiterated: Buy
Price Target: $8
Current: $1.97
Upside: n/a
Oct 11, 2024
Reiterated: Buy
Price Target: $5 → $3
Current: $0.3209
Upside: n/a
Jun 6, 2024
Reiterated: Buy
Price Target: $1.35 → $2
Current: $1.89
Upside: n/a
Apr 15, 2024
Reiterated: Buy
Price Target: $40 → $24
Current: $1.41
Upside: n/a
Apr 8, 2024
Initiated Coverage: Buy
Price Target: $1
Current: $0.3614
Upside: n/a
Sep 21, 2023
Reiterated: Buy
Price Target: $960 → $240
Current: $0.000001
Upside: n/a
Sep 15, 2023
Downgraded: Hold
Price Target: n/a
Current: $26.39
Upside: n/a
Aug 24, 2023
Reiterated: Buy
Price Target: $9 → $5
Current: $2.14
Upside: n/a
Jul 21, 2023
Initiated Coverage: Buy
Price Target: $5
Current: $0.8293
Upside: n/a
Mar 23, 2023
Reiterated: Buy
Price Target: $8 → $4
Current: $2.13
Upside: n/a
Mar 22, 2023
Reiterated: Buy
Price Target: $6
Current: $0.375
Upside: n/a
Jun 29, 2021
Reiterated: Buy
Price Target: $8
Current: $2.89
Upside: n/a
Jul 20, 2018
Initiated Coverage: Buy
Price Target: $27
Current: $1.09
Upside: n/a
Apr 5, 2018
Reiterated: Buy
Price Target: $42
Current: $0.3105
Upside: n/a
Mar 2, 2018
Reiterated: Buy
Price Target: $26 → $38
Current: $55.93
Upside: n/a
Feb 26, 2018
Downgraded: Hold
Price Target: n/a
Current: $3.21
Upside: n/a
Feb 2, 2018
Initiated Coverage: Buy
Price Target: $8
Current: $0.9146
Upside: n/a
Oct 28, 2016
Upgraded: Buy
Price Target: $40 → $92
Current: $14.40
Upside: n/a
Nov 21, 2012
Reiterated: Hold
Price Target: $46
Current: $102.86
Upside: n/a
Mar 2, 2012
Initiated Coverage: Buy
Price Target: n/a
Current: $44.34
Upside: n/a